Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Parvibaculum lavamentivorans GTPase Der (der) CSB-YP415594PYE
CSB-EP415594PYE
CSB-BP415594PYE
CSB-MP415594PYE
CSB-EP415594PYE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Parvibaculum lavamentivorans UPF0102 protein Plav_3586 (Plav_3586) CSB-YP415595PYE
CSB-EP415595PYE
CSB-BP415595PYE
CSB-MP415595PYE
CSB-EP415595PYE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Parvibaculum lavamentivorans Probable rRNA maturation factor (Plav_3619) CSB-YP415596PYE
CSB-EP415596PYE
CSB-BP415596PYE
CSB-MP415596PYE
CSB-EP415596PYE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Parvibaculum lavamentivorans Polyribonucleotide nucleotidyltransferase (pnp), partial CSB-YP415597PYE
CSB-EP415597PYE
CSB-BP415597PYE
CSB-MP415597PYE
CSB-EP415597PYE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Na (+)/H (+) antiporter nhaA 1, partial CSB-YP415598CWD
CSB-EP415598CWD
CSB-BP415598CWD
CSB-MP415598CWD
CSB-EP415598CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis 50S ribosomal protein L23 (rplW) CSB-YP415599CWD
CSB-EP415599CWD
CSB-BP415599CWD
CSB-MP415599CWD
CSB-EP415599CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis 50S ribosomal protein L24 (rplX) CSB-YP415600CWD
CSB-EP415600CWD
CSB-BP415600CWD
CSB-MP415600CWD
CSB-EP415600CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP415601CWD
CSB-EP415601CWD
CSB-BP415601CWD
CSB-MP415601CWD
CSB-EP415601CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis NADH-quinone oxidoreductase subunit N (nuoN), partial CSB-YP415602CWD
CSB-EP415602CWD
CSB-BP415602CWD
CSB-MP415602CWD
CSB-EP415602CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Serine--tRNA ligase (serS) CSB-YP415603CWD
CSB-EP415603CWD
CSB-BP415603CWD
CSB-MP415603CWD
CSB-EP415603CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Probable endonuclease 4 (nfo) CSB-YP415604CWD
CSB-EP415604CWD
CSB-BP415604CWD
CSB-MP415604CWD
CSB-EP415604CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Protease HtpX homolog (htpX), partial CSB-YP415605CWD1
CSB-EP415605CWD1
CSB-BP415605CWD1
CSB-MP415605CWD1
CSB-EP415605CWD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP415606CWD
CSB-EP415606CWD
CSB-BP415606CWD
CSB-MP415606CWD
CSB-EP415606CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis 60 kDa chaperonin (groL), partial CSB-YP415607CWD
CSB-EP415607CWD
CSB-BP415607CWD
CSB-MP415607CWD
CSB-EP415607CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis 50S ribosomal protein L34 (rpmH) CSB-YP415608CWD
CSB-EP415608CWD
CSB-BP415608CWD
CSB-MP415608CWD
CSB-EP415608CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial CSB-YP415609CWD
CSB-EP415609CWD
CSB-BP415609CWD
CSB-MP415609CWD
CSB-EP415609CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Prolipoprotein diacylglyceryl transferase (lgt), partial CSB-YP415610CWD1
CSB-EP415610CWD1
CSB-BP415610CWD1
CSB-MP415610CWD1
CSB-EP415610CWD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B CSB-YP415611CWD
CSB-EP415611CWD
CSB-BP415611CWD
CSB-MP415611CWD
CSB-EP415611CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis tRNA (cmo5U34)-methyltransferase CSB-YP415612CWD
CSB-EP415612CWD
CSB-BP415612CWD
CSB-MP415612CWD
CSB-EP415612CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Uridylate kinase (pyrH) CSB-YP415613CWD
CSB-EP415613CWD
CSB-BP415613CWD
CSB-MP415613CWD
CSB-EP415613CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>